The Massachusetts Research and Development Tax Credit: A Comprehensive Analysis of the Regular Method and Statutory Framework

The Regular Method for the Massachusetts R&D tax credit is a calculation path providing a 10% credit on qualified research expenses that exceed a base amount determined by historical R&D intensity and gross receipts. This method rewards companies that increase their investment in Massachusetts-based innovation relative to their business growth and provides an additional 15% credit for basic research payments.

The Regular Method, often referred to as the Traditional Method or “Option 1” under modern filing instructions, represents the core statutory mechanism for incentivizing scientific and technological advancement within the Commonwealth of Massachusetts. Governed primarily by Massachusetts General Laws Chapter 63, Section 38M, the credit serves as a critical fiscal tool for the state’s high-technology, life sciences, and manufacturing sectors. Historically, the Massachusetts R&D credit was designed to parallel the federal research credit available under Internal Revenue Code Section 41, creating a familiar landscape for corporate tax departments. However, significant legislative revisions enacted in 2014 and effective for tax years beginning on or after January 1, 2015, fundamentally altered the calculation mechanics to modernize the incentive and broaden its accessibility for newer firms and those with complex historical records.1

Statutory Framework and Legislative Evolution

The legal foundation for the Massachusetts Research Credit is codified in M.G.L. ch. 63, § 38M. This statute establishes the eligibility of business corporations to claim a credit against their corporate excise for expenses related to research conducted specifically within the borders of Massachusetts. Unlike many federal provisions that have faced periods of expiration and renewal, the Massachusetts credit is a permanent fixture of the state’s tax code, providing long-term predictability for capital-intensive industries.1

Prior to 2015, the “Regular Method” was heavily tethered to a fixed historical base period spanning from 1983 to 1988, mirroring the federal “Regular Credit” formula. This requirement often proved insurmountable for mature companies that lacked granular records from the 1980s or for start-ups that were forced to use a fixed “start-up” percentage that did not accurately reflect their actual innovation cycles. The passage of “An Act Promoting Economic Growth Across the Commonwealth” (St. 2014, c. 287) sought to rectify these inefficiencies by introducing a rolling lookback period for the Regular Method and creating an Alternative Simplified Method as a secondary option.2

The Department of Revenue (DOR) has issued extensive guidance on these changes through Technical Information Releases (TIRs), notably TIR 14-13 and TIR 14-16, and has promulgated regulations under 830 CMR 63.38M.1 and the more recent Proposed Regulation 830 CMR 63.38M.2. These documents clarify that while the Massachusetts credit generally adopts the definitions of the federal research credit, it maintains specific divergences, particularly regarding the geographic nexus of expenses and the timing of certain elections.2

Core Definitions and Eligibility Requirements

To successfully claim the credit under the Regular Method, a taxpayer must first determine its eligibility as a “business corporation” and ensure that its activities meet the rigorous definitions of “qualified research” and “qualified research expenses.”

Qualified Entities

Eligibility is primarily restricted to business corporations subject to the Massachusetts corporate excise under M.G.L. ch. 63, § 39. This includes both domestic and foreign corporations doing business in the Commonwealth. While the credit has traditionally been viewed as a benefit for manufacturing and technology firms, a landmark 2024 decision by the Appellate Tax Board in State Street Corporation v. Commissioner of Revenue (A.T.B. Docket No. C344139) significantly expanded the eligibility landscape. The Board held that financial institutions subject to the excise under M.G.L. ch. 63, § 2 are also entitled to claim the research tax credit, effectively overturning decades of DOR policy that had restricted the credit to Section 39 filers. The DOR subsequently issued TIR 25-3 to acknowledge this ruling, signaling a broader application of the incentive across the state’s financial services sector.4

For flow-through entities such as S-corporations, the credit is applicable at the entity level against the corporation’s own excise liability, which may include the non-income measure (property or net worth) or the income measure. However, a critical distinction from federal law is that the Massachusetts research credit does not pass through to individual shareholders. This entity-level restriction ensures the credit remains an incentive for the business itself rather than a personal tax reduction for its owners.5

The Geographic Nexus of Research Activity

The most fundamental requirement of the Massachusetts credit is that the research activity must be conducted within the state. Expenses related to services rendered or tangible property used both inside and outside Massachusetts must be carefully prorated. The DOR requires taxpayers to allocate expenses based on the ratio of the number of days a service provider or property was used in Massachusetts to the total number of days employed in the research activity.9

The Four-Part Test for Qualified Research

Massachusetts adopts the federal “four-part test” found in IRC § 41(d) to define qualified research. To qualify, an activity must meet all of the following:

• Section 174 Test: The expenditure must be eligible for deduction as a research and development cost under Section 174 of the Internal Revenue Code.
• Technological in Nature: The research must fundamentally rely on principles of the physical or biological sciences, engineering, or computer science.
• Process of Experimentation: Substantially all of the activities must constitute a process of experimentation involving the evaluation of alternatives to overcome technical uncertainty.
• Permissible Purpose: The research must be intended to develop a new or improved function, performance, reliability, or quality for a business component.4

Mechanics of the Regular Method (Option 1) Calculation

The Regular Method determines the credit amount by comparing current-year innovation spending against a calculated “base amount.” The credit is the sum of 10% of the incremental qualified research expenses and 15% of basic research payments.1

The Incremental Component

The calculation of the 10% incremental credit is the most common application of the Regular Method. The “incremental” nature ensures that the state only subsidizes research spending that exceeds the company’s historical baseline.

Calculating the Base Amount

The base amount represents the threshold that a company must exceed before any credit is generated. Under the modernized Regular Method, the base amount is the product of:

1. The Average Annual Gross Receipts (AAGR) for the four taxable years preceding the credit year.
2. The Fixed-Base Ratio.1

However, the statute provides a “minimum base amount” floor. The base amount used in the final calculation can never be less than 50% of the current year’s qualified research expenses. This floor effectively limits the maximum credit to 5% of total current-year spending if the historical formula would otherwise result in a very low base.1

The Fixed-Base Ratio

The Fixed-Base Ratio is the mechanism that captures a company’s historical research intensity. For tax years beginning on or after January 1, 2015, this ratio is calculated using a rolling lookback period rather than the static 1980s period used previously. The ratio is determined by dividing the total qualified research expenses for the third and fourth taxable years preceding the credit year by the total gross receipts for those same two years.4

If a corporation cannot compute the ratio due to inadequate records, the law mandates the use of a maximum ratio of 16%, which significantly increases the base amount and reduces the potential credit.3

Basic Research Payments Component

The second component of the Regular Method allows for a 15% credit on “basic research payments.” These are defined as payments made to a “qualified organization” for basic research conducted in Massachusetts under a written agreement. Qualified organizations generally include colleges, universities, and certain scientific research organizations.1

The credit is calculated as 15% of the excess of current-year basic research payments over a base period amount. This base period amount is generally the average of basic research payments over a fixed period, as defined under IRC § 41(e). Notably, this 15% add-on is only available under the Regular Method; taxpayers electing the Alternative Simplified Method (ASM) forfeit the ability to claim the basic research component.4

Local Revenue Office Guidance and Administrative Requirements

The Massachusetts Department of Revenue provides the necessary administrative framework for claiming the credit through annual instructions and specific technical releases. Successful compliance hinges on understanding the nuances of the gross receipts election and the documentation standards required for audit defense.

The Gross Receipts Election

One of the most powerful planning tools within the Regular Method is the election to use Massachusetts-sourced gross receipts. Taxpayers have two options for the “gross receipts” portion of the base amount calculation:

1. Federal Gross Receipts (Default): The calculation uses the taxpayer’s total global gross receipts as reported for federal income tax purposes.
2. Massachusetts Gross Receipts (Election): The taxpayer elects to use only those receipts attributable to activities within Massachusetts.5

If the taxpayer elects to use Massachusetts receipts, they must consistently apply this data set to both the Average Annual Gross Receipts (the 4-year average) and the Fixed-Base Ratio (the 3rd and 4th preceding years). This election is typically made on the original return and is binding for three years.7

For a multinational corporation with high global sales but focused research operations in Massachusetts, electing Massachusetts receipts can drastically lower the base amount, thereby significantly increasing the credit generated. Conversely, for companies with a high concentration of sales in Massachusetts, the federal default might result in a more favorable (higher) Fixed-Base Ratio if their historical R&D intensity was higher on a global scale.

Schedule RC and Filing Procedures

The credit must be claimed on Schedule RC (Research Credit), which is filed alongside the corporate excise return. Part 1 of Schedule RC guides the taxpayer through the generation of the credit, requiring the explicit selection of “Option 1” for the Traditional/Regular Method or “Option 2” for the ASM.5

Taxpayers must also comply with the “add-back” requirement. Under Massachusetts law, any research expenses that generate a credit must be added back to the corporation’s taxable income. This prevents a “double dip” where a company would otherwise benefit from both a 100% deduction of the expenses and a 10% tax credit.5

Aggregated Group Rules

Corporations that are members of a controlled group or under common control (as defined in IRC § 41(f)(1)(A)) must calculate the credit on an aggregated basis. The group is treated as a single taxpayer for the purposes of determining the total credit generated. All qualified expenses and receipts of the group members are summed, and inter-company payments are eliminated.4

Once the total group credit is determined, it is allocated among the individual members based on each corporation’s share of the group’s total qualified research expenses. This aggregated approach prevents the manipulation of credits through the shifting of expenses between related entities.4

Comparison of Calculation Methods

Choosing between the Regular Method and the Alternative Simplified Method (ASM) requires an annual analysis of a company’s historical data. While the Regular Method is often more complex, it can yield a higher credit for certain profiles.

The ASM is generally attractive for companies with volatile revenue but steady R&D spending, or for those whose records from prior years are missing. The Regular Method remains the gold standard for companies with low gross receipts in Massachusetts relative to their R&D spend, or for those making significant basic research payments to universities.3

Regular Method Calculation Example

To demonstrate the application of the Regular Method and the Massachusetts gross receipts election, consider “TechSolutions Inc.,” a mid-sized software developer with expanding operations in Boston.

TechSolutions Inc. Historical Data (Hypothetical)

Step 1: Calculate the Fixed-Base Ratio (Using MA Receipts Election)

TechSolutions elects to use Massachusetts-only gross receipts. The ratio uses data from the 3rd and 4th preceding years (2020 and 2021).

• Total QRE (2020-2021): $\$900,000 + \$1,100,000 = \$2,000,000$
• Total MA Receipts (2020-2021): $\$8,000,000 + \$9,000,000 = \$17,000,000$
• Fixed-Base Ratio: $\$2,000,000 / \$17,000,000 = 0.1176$ (or 11.76%).5

Step 2: Calculate Average Annual Gross Receipts (AAGR)

The AAGR is the average of the four preceding years (2020-2023) using the same MA receipts data.

• Total MA Receipts (4 yrs): $\$8M + \$9M + \$10M + \$11M = \$38,000,000$
• AAGR: $\$38,000,000 / 4 = \$9,500,000$.4

Step 3: Determine the Base Amount

• Calculated Base Amount: $\$9,500,000 \times 0.1176 = \$1,117,200$
• Check Minimum Floor (50% of current QRE): $\$1,500,000 \times 0.50 = \$750,000$
• Final Base Amount: $1,117,200 (Since it is greater than the floor).1

Step 4: Final Credit Generation

• Incremental QRE: $\$1,500,000 – \$1,117,200 = \$382,800$
• Total Regular Credit (10%): $\$382,800 \times 0.10 = \mathbf{\$38,280}$.1

Statutory Limitations and Carryover Provisions

Generating the credit is only the first stage of the process. Taxpayers must then navigate the complex “utilization caps” that govern how much of the generated credit can actually offset their excise tax in a given year.

The $25,000 and 75% Rule

The Massachusetts research credit is subject to a strict limitation based on the corporation’s total excise liability. A corporation can use the credit to offset:

1. 100% of its first $25,000 of corporate excise liability.
2. 75% of any excise liability exceeding $25,000.1

For members of an aggregated group, the $25,000 threshold is not granted to each member; instead, a single $25,000 amount must be shared and apportioned among the group members according to DOR regulations.1

The $456 Minimum Excise Floor

Regardless of the amount of research credits generated, a corporation’s excise tax cannot be reduced below the statutory minimum tax. For most business corporations, this floor is $456.7 If a company’s tax liability before credits is already at or near $456, its current-year credit utilization will be effectively zero, and the entire credit will be carried forward.

Carryforward Mechanisms

Because of these strict limitations, many high-innovation companies accumulate significant “excess” credits. Massachusetts law provides two different carryover tracks based on why the credit was restricted:

• 15-Year Carryover: Credits that exceed the 100%/75% utilization cap or the current year’s liability can generally be carried forward for 15 years.1
• Indefinite Carryover: Credits that are disallowed specifically due to the “75% of excise over $25,000” rule may be carried forward indefinitely. This unique provision ensures that the most research-intensive firms do not lose the value of their incentives simply because they have a high tax liability.7

Sector-Specific Provisions: Life Sciences and Defense

Massachusetts tailors the Regular Method through specialized programs for its two most critical innovation sectors: life sciences and defense.

The Life Sciences Tax Incentive Program

The Massachusetts Life Sciences Center (MLSC) administers a discretionary program that can transform the standard research credit from a non-refundable offset into a cash refund. Certified life sciences companies may apply annually to the MLSC for the right to “refund” their unused research credits at 90% of their face value. This is particularly valuable for early-stage biotechnology firms that are pre-revenue and have high R&D spending but no tax liability to offset.7

Companies must apply during a specific window (typically February to June) and must meet job creation targets to qualify for these allocations. The program is capped annually, making it a competitive but high-value enhancement to the standard § 38M credit.19

Defense-Related Activities and the 2024 Expansion

Section 38M(i) allows corporations to elect to calculate their research credit separately for defense-related activities. This “defense-related” calculation can be advantageous if a company’s military research has a different spending profile or gross receipt history than its commercial side.1

Effective for 2024, the definition of defense-related activities was significantly expanded. It now includes:

1. Chemical/Biological/Radiological/Nuclear (CBRN) Threats: Research into medicines and medical supplies used to diagnose, prevent, or treat diseases related to these threats.
2. Biologics and Vaccines: Research into biologic products, vaccines, blood products, and antibodies.
3. Traditional Munitions: Activities related to arms, ammunition, or implements of war as designated in the federal munitions list.5

This expansion reflects the growing intersection between the life sciences and national security sectors in Massachusetts, providing biotech firms working on public health defense with access to the specialized defense-related credit calculation.

Statistical Analysis of the Credit’s Fiscal Impact

The research credit is one of the Commonwealth’s most significant tax expenditures, reflecting the high concentration of R&D-driven industries in the region.

Tax Expenditure Estimates (FY 2021 – FY 2025)

Data from the Massachusetts Department of Revenue and the Executive Office for Administration and Finance highlights the projected revenue impact of the credit.

Note: The FY 2024 and 2025 projections show a steady increase, likely driven by the 2021 increase in the ASM rate to 10% and the expansion of defense definitions..15

Life Sciences Refundable Credit Allocations (2023)

The 2023 Tax Credit Transparency Report provides a snapshot of the refundable portion of the life sciences research credit.

While the general R&D credit is claimed by hundreds of corporations, the refundable program is targeted at a smaller group of high-growth, job-creating biotech firms.27

Practical Compliance Strategies and Audit Risk

Given the complexity of the Regular Method, particularly the historical lookback for the Fixed-Base Ratio, companies must adopt rigorous compliance strategies to survive DOR examinations.

Documentation Standards

The DOR Proposed Regulation 830 CMR 63.38M.2(16) explicitly requires corporations to maintain “adequate records” to substantiate the credit calculation. In the context of the Regular Method, this includes:

• Historical Receipts: Ledgers and tax returns for the prior four years to support the AAGR.
• Lookback QREs: Detailed project accounting for the third and fourth preceding years to justify the Fixed-Base Ratio.
• Payroll Allocation: Records showing the percentage of time employees spent on qualified activities vs. non-qualified activities.
• Contract Research: Copies of written agreements with third-party researchers and proof that the work was performed in Massachusetts.5

Audit Trends and the State Street Ruling

With the 2024 State Street ruling, the DOR is expected to see a surge in amended returns from financial institutions seeking to claim credits for previous years. However, the DOR has signaled a strict stance on the timing of elections. For example, the Alternative Simplified Method (ASM) must be elected on an original return and cannot generally be claimed for the first time on an amended return or abatement application.6 This makes the Regular Method the likely default for many companies filing amended returns to capture “missed” R&D credits for past years, provided they can satisfy the historical data requirements.

Audit risk remains high for the proration of wages for “dual-location” employees. Large software companies with remote workforces must be prepared to prove that the work was actually performed within the borders of Massachusetts, as time spent working from a home office in New Hampshire or Rhode Island is strictly ineligible.9

Interplay with Federal Tax Law: The Section 174 Impact

A major development in recent years that affects the utility of the Massachusetts R&D credit is the federal change to Section 174 expense treatment. Starting in 2022, the federal “Tax Cuts and Jobs Act” (TCJA) required businesses to capitalize and amortize R&D expenses over 5 years (for domestic) or 15 years (for foreign), rather than deducting them immediately.

While Massachusetts generally conforms to the IRC as of specific dates, the “add-back” requirement and the state’s reliance on the federal definition of QREs create a complex interaction. Businesses must ensure that their state-level “add-back” of the credit amount is calculated correctly in light of these federal amortization schedules to avoid overpaying or underpaying their state income measure.3

Strategic Planning for Controlled Groups and Partnerships

For large corporate families, the Regular Method requires careful coordination. Since the group is treated as a single taxpayer, a high-spending subsidiary in Massachusetts can generate credits that offset the tax liability of a profitable, non-R&D subsidiary within the same combined group return.

Aggregated Group Allocation Example

Consider a group with two members: “R&D Sub” and “Profit Sub.”

In this scenario, R&D Sub generates the entire $100,000 credit for the group. Under Massachusetts combined filing rules, Profit Sub can use its share of the $25,000 threshold to help utilize that credit, provided the group-wide limitations are met.4

Partnership Flow-Through Mechanics

When a corporation is a partner in a partnership that conducts R&D, the partnership’s QREs and gross receipts are attributed to the corporate partners based on their ownership percentage. The corporation then incorporates these “flow-through” amounts into its own Schedule RC calculation. This ensures that the R&D performed by joint ventures or specialized R&D partnerships is still incentivized at the corporate owner level.4

Conclusion: The Enduring Value of the Regular Method

The Regular Method of the Massachusetts Research and Development tax credit remains a sophisticated and high-value incentive for corporations deeply invested in the Commonwealth’s innovation economy. By shifting to a rolling lookback period and maintaining a higher potential credit through the inclusion of basic research payments, the Regular Method offers significant advantages over the Alternative Simplified Method for businesses with stable growth profiles and strong university partnerships.

For corporate tax professionals, the key to maximizing the value of the Regular Method lies in the strategic use of the Massachusetts gross receipts election and the diligent maintenance of contemporaneous records. As the legal landscape evolves—marked by the inclusion of financial institutions and the expansion of defense-related definitions—the Regular Method will continue to serve as a cornerstone of Massachusetts’ efforts to attract and retain the world’s leading technology and life sciences organizations. The combination of a 10% incremental rate, indefinite carryforwards for certain disallowed portions, and the potential for 90% refundability for life sciences firms creates a world-class incentive program that directly supports the reinvestment of capital into the state’s workforce and scientific infrastructure.

In a competitive global market for innovation, the Massachusetts R&D credit, and specifically its Regular Method, provides the long-term fiscal stability required for multi-year research projects that drive breakthroughs in medicine, national security, and sustainable technology. As the Department of Revenue finalizes new regulations to reflect recent legislative changes, taxpayers must remain vigilant in their documentation and annual modeling to ensure they are capturing the full scope of this essential state incentive.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/